Skip to content

Study · Ex vivo tissue · 2025

7 results

Assessing The Effectiveness of Growth Hormone Releasing Protein-6 in Improving Human Oocyte Maturation and Meiotic Progression in In Vitro Maturation Culture Media.

Ostadian C, Hayati N, Zahiri Sorouri Z, Hosseini A

International journal of fertility & sterility30 Sept 2025Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study7

7 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueEfficacy outcome

    In cultured human oocytes, GHRP‑6 yielded 70% maturation on the first day, exceeding blastocyst medium.

    In plain wordsIn lab tests, human oocyte maturation reached 70% with GHRP‑6 on the first day, exceeding blastocyst medium.

    Peptide
    GHRP-6
    Outcome
    IncreaseFirst-day maturation rate versus blastocyst medium
    Study

    humann: not reported in source

    Human germinal vesicle oocytes in maturation culture
    Comparator
    Blastocyst medium
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    75 ng/ml · culture medium · 1 dayAs given in this study (human).

    Measurements

    Maturation rate
    70%
    first day; GHRP-6 75 ng/ml

    Source sentences

    Summary
    The optimal concentration of GHRP-6 for the IVM procedure was determined to be 75 ng/ml, resulting in a maturation rate of 70% on the first day and 80% on the second day.
    3 context sentences
    Summary · context
    These results surpassed those of other culture media on both days.
    Summary · context
    In this experimental study, a total of 240 human germinal vesicle (GV) oocytes were collected and cultured in varying concentrations of GHRP-6.
    Summary · context
    Maturation rates were assessed during two days of culture, and compared against a blastocyst media (single-step culture) as control group and another IVM media, human tubal fluid (HTF) 10%, as the sham group.
  2. 02LabEx vivo tissueEfficacy outcome

    In cultured human oocytes, GHRP‑6 yielded 70% maturation on the first day, exceeding HTF medium.

    In plain wordsIn lab tests, human oocyte maturation reached 70% with GHRP‑6 on the first day, exceeding HTF medium.

    Peptide
    GHRP-6
    Outcome
    IncreaseFirst-day maturation rate versus HTF medium
    Study

    humann: not reported in source

    Human germinal vesicle oocytes in maturation culture
    Comparator
    HTF 10% medium
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    75 ng/ml · culture medium · 1 dayAs given in this study (human).

    Measurements

    Maturation rate
    70%
    first day; GHRP-6 75 ng/ml

    Source sentences

    Summary
    The optimal concentration of GHRP-6 for the IVM procedure was determined to be 75 ng/ml, resulting in a maturation rate of 70% on the first day and 80% on the second day.
    3 context sentences
    Summary · context
    These results surpassed those of other culture media on both days.
    Summary · context
    In this experimental study, a total of 240 human germinal vesicle (GV) oocytes were collected and cultured in varying concentrations of GHRP-6.
    Summary · context
    Maturation rates were assessed during two days of culture, and compared against a blastocyst media (single-step culture) as control group and another IVM media, human tubal fluid (HTF) 10%, as the sham group.
  3. 03LabEx vivo tissueEfficacy outcome

    In cultured human oocytes, GHRP‑6 yielded 80% maturation on the second day, exceeding blastocyst medium.

    In plain wordsIn lab tests, human oocyte maturation reached 80% with GHRP‑6 on the second day, exceeding blastocyst medium.

    Peptide
    GHRP-6
    Outcome
    IncreaseSecond-day maturation rate versus blastocyst medium
    Study

    humann: not reported in source

    Human germinal vesicle oocytes in maturation culture
    Comparator
    Blastocyst medium
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    75 ng/ml · culture medium · 2 daysAs given in this study (human).

    Measurements

    Maturation rate
    80%
    second day; GHRP-6 75 ng/ml

    Source sentences

    Summary
    The optimal concentration of GHRP-6 for the IVM procedure was determined to be 75 ng/ml, resulting in a maturation rate of 70% on the first day and 80% on the second day.
    3 context sentences
    Summary · context
    These results surpassed those of other culture media on both days.
    Summary · context
    In this experimental study, a total of 240 human germinal vesicle (GV) oocytes were collected and cultured in varying concentrations of GHRP-6.
    Summary · context
    Maturation rates were assessed during two days of culture, and compared against a blastocyst media (single-step culture) as control group and another IVM media, human tubal fluid (HTF) 10%, as the sham group.
  4. 04LabEx vivo tissueEfficacy outcome

    In cultured human oocytes, GHRP‑6 yielded 80% maturation on the second day, exceeding HTF medium.

    In plain wordsIn lab tests, human oocyte maturation reached 80% with GHRP‑6 on the second day, exceeding HTF medium.

    Peptide
    GHRP-6
    Outcome
    IncreaseSecond-day maturation rate versus HTF medium
    Study

    humann: not reported in source

    Human germinal vesicle oocytes in maturation culture
    Comparator
    HTF 10% medium
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    75 ng/ml · culture medium · 2 daysAs given in this study (human).

    Measurements

    Maturation rate
    80%
    second day; GHRP-6 75 ng/ml

    Source sentences

    Summary
    The optimal concentration of GHRP-6 for the IVM procedure was determined to be 75 ng/ml, resulting in a maturation rate of 70% on the first day and 80% on the second day.
    3 context sentences
    Summary · context
    These results surpassed those of other culture media on both days.
    Summary · context
    In this experimental study, a total of 240 human germinal vesicle (GV) oocytes were collected and cultured in varying concentrations of GHRP-6.
    Summary · context
    Maturation rates were assessed during two days of culture, and compared against a blastocyst media (single-step culture) as control group and another IVM media, human tubal fluid (HTF) 10%, as the sham group.
  5. 05LabEx vivo tissueMechanism

    In cultured human oocytes, GHRP‑6 did not elevate CENP-E expression despite early first polar body appearance.

    In plain wordsIn lab tests, GHRP‑6 did not increase CENP-E gene expression in human oocytes.

    Peptide
    GHRP-6
    Outcome
    No significant changeCENP-E expression
    Study

    humann: not reported in source

    Human germinal vesicle oocytes in maturation culture
    Comparator
    Control and sham culture groups
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    75 ng/ml · culture medium · 24 hoursAs given in this study (human).

    Source sentences

    Summary
    Real-time PCR data indicated that, despite the early appearance of the first polar body (PB1) on 24h of culture, the Ghrelin agonist did not elevate the expression levels of CENP-E or LINGO2, genes associated with meiotic progression and membrane proteins, respectively.
    3 context sentences
    Summary · context
    Additionally, the expression levels of two genes associated with nuclear and cytoplasmic maturation were compared in the number of 164 GV oocytes randomly cultured in the most effective concentration of GHRP-6, control and sham groups for 24 hours, using real-time polymerase chain reaction (PCR).
    Summary · context
    In this experimental study, a total of 240 human germinal vesicle (GV) oocytes were collected and cultured in varying concentrations of GHRP-6.
    Summary · context
    Maturation rates were assessed during two days of culture, and compared against a blastocyst media (single-step culture) as control group and another IVM media, human tubal fluid (HTF) 10%, as the sham group.
  6. 06LabEx vivo tissueMechanism

    In cultured human oocytes, GHRP‑6 did not elevate LINGO2 expression despite early first polar body appearance.

    In plain wordsIn lab tests, GHRP‑6 did not increase LINGO2 gene expression in human oocytes.

    Peptide
    GHRP-6
    Outcome
    No significant changeLINGO2 expression
    Study

    humann: not reported in source

    Human germinal vesicle oocytes in maturation culture
    Comparator
    Control and sham culture groups
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    75 ng/ml · culture medium · 24 hoursAs given in this study (human).

    Source sentences

    Summary
    Real-time PCR data indicated that, despite the early appearance of the first polar body (PB1) on 24h of culture, the Ghrelin agonist did not elevate the expression levels of CENP-E or LINGO2, genes associated with meiotic progression and membrane proteins, respectively.
    3 context sentences
    Summary · context
    Additionally, the expression levels of two genes associated with nuclear and cytoplasmic maturation were compared in the number of 164 GV oocytes randomly cultured in the most effective concentration of GHRP-6, control and sham groups for 24 hours, using real-time polymerase chain reaction (PCR).
    Summary · context
    In this experimental study, a total of 240 human germinal vesicle (GV) oocytes were collected and cultured in varying concentrations of GHRP-6.
    Summary · context
    Maturation rates were assessed during two days of culture, and compared against a blastocyst media (single-step culture) as control group and another IVM media, human tubal fluid (HTF) 10%, as the sham group.
  7. 07LabEx vivo tissueEfficacy outcome

    In cultured human oocytes receiving GHRP‑6, the first polar body appeared early during culture.

    In plain wordsIn lab tests, human oocytes receiving GHRP‑6 showed early first polar body appearance.

    Peptide
    GHRP-6
    Outcome
    Not applicableEarly first polar body appearance
    Study

    humann: not reported in source

    Human germinal vesicle oocytes in maturation culture
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    75 ng/ml · culture medium · 24 hoursAs given in this study (human).

    Source sentences

    Summary
    Real-time PCR data indicated that, despite the early appearance of the first polar body (PB1) on 24h of culture, the Ghrelin agonist did not elevate the expression levels of CENP-E or LINGO2, genes associated with meiotic progression and membrane proteins, respectively.
    3 context sentences
    Summary · context
    Additionally, the expression levels of two genes associated with nuclear and cytoplasmic maturation were compared in the number of 164 GV oocytes randomly cultured in the most effective concentration of GHRP-6, control and sham groups for 24 hours, using real-time polymerase chain reaction (PCR).
    Summary · context
    In this experimental study, a total of 240 human germinal vesicle (GV) oocytes were collected and cultured in varying concentrations of GHRP-6.
    Summary · context
    Maturation rates were assessed during two days of culture, and compared against a blastocyst media (single-step culture) as control group and another IVM media, human tubal fluid (HTF) 10%, as the sham group.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.